References
Telemedicine
1. Centers for Medicare & Medicaid Services. End Stage Renal Disease (ESRD) Facilities: CMS Flexibilities to Fight COVID-19. November 4, 2020. https://www.cms.gov/files/document/covid-19-esrd-facilities.pdf
Home dialysis
2. Sachdeva M, et al. Home dialysis in the time of COVID-19: Reflections on rapidly changing policies [published online ahead of print November 23, 2020]. Kidney Med doi: 10.1016/j.xkme.2020.09.008; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685041/
Transplant rates
3. Loupy A, et al. Organ procurement and transplantation during the COVID-19 pandemic. Lancet 2020; 395:e95–e96. doi: 10.1016/S0140-6736(20)31040-0
New therapies and vaccines
4. National Institutes of Health. COVID-19 Treatment Guidelines: Corticosteroids. November 3, 2020. https://www.covid19treatmentguidelines.nih.gov/immune-based-therapy/immunomodulators/corticosteroids/
5. US Food and Drug Administration. COVID-19 Vaccines. November 30, 2020. https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/covid-19-vaccines
Kidney outcomes secondary to AKI
6. Ng JH, et al. Outcomes among patients hospitalized with COVID-19 and acute kidney injury [published online ahead of print September 19, 2020]. Am J Kidney Dis doi: 10.1053/j.ajkd.2020.09.002; https://www.ajkd.org/article/S0272-6386(20)30998-7/fulltext
Psychosocial impact
7. Lee J, et al. Psychosocial impact of COVID-19 pandemic on patients with end-stage kidney disease on hemodialysis. Kidney360 October 2020. doi: 10.34067/KID.0004662020; https://kidney360.asnjournals.org/content/early/2020/10/20/KID.0004662020
